The Association of Tumor-Infiltrating Lymphocytes and Programmed Cell Death 1 Expression with the Incidence of Distant Metastasis in Triple-Negative Breast Cancer Subjects in Sanglah General Hospital, Bali, Indonesia

被引:0
|
作者
Sudarsa, I. Wayan [1 ]
Gunawan, I. Putu Ari [1 ]
Manuaba, Ida Bagus Tjakra Wibawa [1 ]
机构
[1] Udayana Univ, Sanglah Gen Hosp, Fac Med, Div Surg Oncol,Dept Surg, Jalan Kesehatan 1, Denpasar 80114, Bali, Indonesia
来源
CASE REPORTS IN ONCOLOGY | 2021年 / 14卷 / 01期
关键词
Triple-negative breast cancer; Programmed cell death-ligand 1; Tumor-infiltrating lymphocytes; Distant metastasis;
D O I
10.1159/000514272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with a high rate of distant metastasis. The tumor immunity microenvironment plays an important role, including tumor-infiltrating lymphocytes (TIL) and PD-1 (programmed cell death 1)/PD-L1 (programmed cell death-ligand 1), in promoting TNBC aggressiveness. This study aimed to determine the association of TIL and PD-L1 expression with the incidence of distant metastasis in TNBC. This study is a cross-sectional study involving TNBC subjects at Sanglah General Hospital, Denpasar, conducted in 2019. The parameters analyzed were the expression of TIL, PD-L1, and the incidence of distant metastasis. The expression of TIL was analyzed histopathologically while PD-L1 was measured with Ventana PD-L1 kit test. Subject characteristics were obtained from medical records. Data were collected and analyzed by SPSS 22.0. As many as 31 subjects with TNBC were included in this study, with 51.6% subjects with distant metastasis. The majority of subjects with distant metastasis had low TIL and low tumoral PD-L1 but high PD-L1 stromal in TIL. From statistical analysis, only PD-L1 stromal in TIL expression was associated significantly with distant metastasis (p = 0.043). In conclusion, there was a significant association between PD-L1 stromal in TIL and the incidence of distant metastasis in TNBC.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [41] The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
    Tomioka, Nobumoto
    Azuma, Manabu
    Ikarashi, Mayuko
    Yamamoto, Mitsugu
    Sato, Masako
    Watanabe, Ken-ichi
    Yamashiro, Katsushige
    Takahashi, Masato
    BREAST CANCER, 2018, 25 (01) : 34 - 42
  • [42] The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
    Nobumoto Tomioka
    Manabu Azuma
    Mayuko Ikarashi
    Mitsugu Yamamoto
    Masako Sato
    Ken-ichi Watanabe
    Katsushige Yamashiro
    Masato Takahashi
    Breast Cancer, 2018, 25 : 34 - 42
  • [43] Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
    Lotfinejad, Parisa
    Asghari Jafarabadi, Mohammad
    Abdoli Shadbad, Mahdi
    Kazemi, Tohid
    Pashazadeh, Fariba
    Sandoghchian Shotorbani, Siamak
    Jadidi Niaragh, Farhad
    Baghbanzadeh, Amir
    Vahed, Nafiseh
    Silvestris, Nicola
    Baradaran, Behzad
    DIAGNOSTICS, 2020, 10 (09)
  • [44] A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
    Criscitiello, C.
    Bayar, M. A.
    Curigliano, G.
    Symmans, F. W.
    Desmedt, C.
    Bonnefoi, H.
    Sinn, B.
    Pruneri, G.
    Vicier, C.
    Pierga, J. Y.
    Denkert, C.
    Loibl, S.
    Sotiriou, C.
    Michiels, S.
    Andre, F.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 162 - 169
  • [45] Intrinsic Prognostic Impact of Tumor-infiltrating Lymphocytes in Systemically Untreated Patients With Early-stage Triple-negative Breast Cancer
    Park, Ji Hyun
    Lee, Hee Jin
    Lee, Sae Byul
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Jung, Kyung Hae
    Gong, Gyungyub
    Son, Byung-Ho
    Ahn, Sei-Hyun
    Kim, Sung-Bae
    ANTICANCER RESEARCH, 2019, 39 (06) : 3111 - 3119
  • [46] PROGNOSIS-RELATED NOVEL IMMUNOSTAINING PATTERN FOR PROGRAMMED CELL DEATH LIGAND 1 AND PROGNOSTIC VALUE OF TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE-NEGATIVE BREAST CANCER
    Savas, Pinar
    Serin, Gurdeniz
    Gursoy, Pinar
    Zekioglu, Osman
    Ozdemir, Necmettin
    POLISH JOURNAL OF PATHOLOGY, 2023, 74 (02) : 65 - 74
  • [47] Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-BasedNeoadjuvant Chemotherapy
    Rao, Nanyan
    Qiu, Jiayin
    Wu, Jiannan
    Zeng, Hong
    Su, Fengxi
    Qiu, Kaifeng
    Wu, Junyan
    Yao, Herui
    CHEMOTHERAPY, 2017, 62 (04) : 246 - 255
  • [48] Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple-negative breast cancer
    Imanishi, Seiichi
    Morishima, Hirotaka
    Gotoh, Takayoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1167 - 1175
  • [49] Expression and Clinical Significance of Programmed Death Ligand-1 and Nucleophosmin in Triple-Negative Breast Cancer
    Jiang, Yiting
    Lian, Yuane
    Chen, Hu
    Huang, Jianping
    Zhang, Shihan
    Yang, Yinghong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (06) : 3283 - 3287
  • [50] Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
    Abuhadra, Nour
    Sun, Ryan
    Litton, Jennifer K.
    Rauch, Gaiane M.
    Yam, Clinton
    Chang, Jeffrey T.
    Seth, Sahil
    Bassett, Roland, Jr.
    Lim, Bora
    Thompson, Alastair M.
    Mittendorf, Elizabeth
    Adrada, Beatriz E.
    Damodaran, Senthil
    White, Jason
    Ravenberg, Elizabeth
    Candelaria, Rosalind
    Arun, Banu
    Ueno, Naoto T.
    Santiago, Lumarie
    Saleem, Sadia
    Abouharb, Sausan
    Murthy, Rashmi K.
    Ibrahim, Nuhad
    Sahin, Aysegul A.
    Valero, Vicente
    Symmans, William Fraser
    Tripathy, Debu
    Moulder, Stacy
    Huo, Lei
    CANCERS, 2022, 14 (05)